REVENUE (Tables)

3 Months Ended

Mar. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregated Revenue

The following table represents disaggregated net product sales in the periods presented as follows (in thousands):

	Three Months Ended March 31,
	2021		2020
Net product sales:
EXPAREL / bupivacaine liposome injectable suspension	$	115,470	$	102,475
iovera°	3,268		2,270
Total net product sales	$	118,738	$	104,745